PL439126A1 - Preparat witaminy B12 oraz sposób jego wytwarzania - Google Patents
Preparat witaminy B12 oraz sposób jego wytwarzaniaInfo
- Publication number
- PL439126A1 PL439126A1 PL439126A PL43912621A PL439126A1 PL 439126 A1 PL439126 A1 PL 439126A1 PL 439126 A PL439126 A PL 439126A PL 43912621 A PL43912621 A PL 43912621A PL 439126 A1 PL439126 A1 PL 439126A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- vitamin
- inulin
- weight ratio
- lecithin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem wynalazku jest preparat witaminy B12 w postaci proszku, w którym dwuwarstwa lipidowa liposomów zawiera lecytynę, który to preparat zawiera inulinę, jako stabilizator, przy czym stosunek wagowy witaminy B12 do lecytyny mieści się w zakresie od 1 : 1 do 1 : 100, natomiast stosunek wagowy lecytyny do inuliny mieści się w zakresie od 1 : 0,1 do 1 : 5. Zaletą rozwiązania według wynalazku jest to, że obecność inuliny stabilizuje preparat liposomów i zapobiega tworzeniu agregatów liposomów, szczególnie w warunkach odpowiadających warunkom kwasu żołądkowego. Wynalazek dostarcza również kapsułkę twardą zawierającą preparat witaminy B12 według wynalazku oraz sposób otrzymywania przedmiotowego preparatu liposomowego.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL439126A PL439126A1 (pl) | 2021-10-04 | 2021-10-04 | Preparat witaminy B12 oraz sposób jego wytwarzania |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL439126A PL439126A1 (pl) | 2021-10-04 | 2021-10-04 | Preparat witaminy B12 oraz sposób jego wytwarzania |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL439126A1 true PL439126A1 (pl) | 2023-04-11 |
Family
ID=85983085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL439126A PL439126A1 (pl) | 2021-10-04 | 2021-10-04 | Preparat witaminy B12 oraz sposób jego wytwarzania |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL439126A1 (pl) |
-
2021
- 2021-10-04 PL PL439126A patent/PL439126A1/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015012200A (es) | Composiciones de oxaliplatino en liposomas para la terapia contra el cancer. | |
| WO2011092708A3 (en) | Liposomes comprising amphipathic drugs and method for their preparation | |
| BR112013000244A2 (pt) | lipossomas com lipídeos apresentando pka vantajoso para administração de rna | |
| SG11201906708WA (en) | Stable and liposoluble active ingredient composition, microcapsule, and preparation method and application thereof | |
| EP4309657A3 (en) | Remote loading of sparingly water-soluble drugs into liposomes | |
| JP2015515992A5 (pl) | ||
| MX341989B (es) | Liposomas pequeños para el suministro de arn que codifica el inmunogeno. | |
| WO2012021107A3 (en) | A liposomal formulation for ocular drug delivery | |
| Neves et al. | Resveratrol induces ordered domains formation in biomembranes: Implication for its pleiotropic action | |
| WO2013004234A3 (en) | Methods for producing liposomes | |
| MX2020002231A (es) | Composiciones anestesicas de liberacion sostenida, y metodos de preparacion de las mismas. | |
| MX2012012914A (es) | Proceso para elaborar composiciones liquidas suavizantes de telas. | |
| MX2023005018A (es) | Liposomas que contienen un agonista de tlr4, preparacion y usos de los mismos. | |
| MX2020014051A (es) | Emulsion lipidica para administracion parenteral. | |
| SG10201808984WA (en) | Method for assessing and treating or preventing impaired plasma polar lipid levels | |
| PL439126A1 (pl) | Preparat witaminy B12 oraz sposób jego wytwarzania | |
| Hudiyanti et al. | Cholesterol implications on coconut liposomes encapsulation of beta-carotene and vitamin C | |
| PL383287A1 (pl) | Kompozycja lipidowa do wytwarzania lipidowego nośnika dla leków genetycznych i jej zastosowanie | |
| JP2005525335A (ja) | Ｎ−アシル−ホスファチジル−エタノールアミン類及び／又はｎ−アシル−エタノールアミン類とホスファチジン酸類又はリゾホスファチジン酸類との混合物 | |
| JP2018527335A5 (pl) | ||
| MX2020010290A (es) | Composiciones anestesicas de liberacion sostenida y metodos de preparacion de las mismas. | |
| NZ598082A (en) | Pharmaceutical composition including a dha ester to be parenterally administered | |
| PE20220942A1 (es) | COMPOSICION DE UN INHIBIDOR DE PI4KIIIalfa DE MOLECULA PEQUENA, METODO DE PREPARACION Y APLICACION DEL MISMO | |
| PL440164A1 (pl) | Preparat witaminowy zawierający witaminy A, D, E, K, twarda dojelitowa kapsułka żelowa zawierająca preparat witaminowy oraz sposób jego wytwarzania | |
| PL440166A1 (pl) | Preparat witaminy B kompleks, twarda dojelitowa kapsułka żelowa zawierająca preparat witaminowy oraz sposób jego wytwarzania |